U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory Sinonasal Squamous Cell Carcinoma

MedGen UID:
1661272
•Concept ID:
C4725008
•
Neoplastic Process
Synonym: Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

Definition

Nasal cavity and paranasal sinus squamous cell carcinoma that does not respond to treatment. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRefractory Sinonasal Squamous Cell Carcinoma

Recent clinical studies

Etiology

Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study.
Ueda Y, Okano S, Enokida T, Fujisawa T, Ito K, Sato M, Tanaka H, Wada A, Tahara M
Oral Oncol 2022 Jul;130:105932. Epub 2022 May 27 doi: 10.1016/j.oraloncology.2022.105932. PMID: 35636078

Diagnosis

Proliferative verrucous leukoplakia and its related lesions.
Batsakis JG, Suarez P, el-Naggar AK
Oral Oncol 1999 Jul;35(4):354-9. doi: 10.1016/s1368-8375(99)00007-x. PMID: 10645398

Therapy

Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study.
Ueda Y, Okano S, Enokida T, Fujisawa T, Ito K, Sato M, Tanaka H, Wada A, Tahara M
Oral Oncol 2022 Jul;130:105932. Epub 2022 May 27 doi: 10.1016/j.oraloncology.2022.105932. PMID: 35636078

Prognosis

Proliferative verrucous leukoplakia and its related lesions.
Batsakis JG, Suarez P, el-Naggar AK
Oral Oncol 1999 Jul;35(4):354-9. doi: 10.1016/s1368-8375(99)00007-x. PMID: 10645398

Clinical prediction guides

Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study.
Ueda Y, Okano S, Enokida T, Fujisawa T, Ito K, Sato M, Tanaka H, Wada A, Tahara M
Oral Oncol 2022 Jul;130:105932. Epub 2022 May 27 doi: 10.1016/j.oraloncology.2022.105932. PMID: 35636078

Supplemental Content

Table of contents

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...